These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

265 related items for PubMed ID: 9920958

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [TNF antagonists in therapy of rheumatoid arthritis].
    Oberpichler-Schwenk H.
    Med Monatsschr Pharm; 1999 Nov; 22(11):334-9. PubMed ID: 10596266
    [No Abstract] [Full Text] [Related]

  • 3. Severe refractory rheumatoid arthritis successfully treated with combination rituximab and anti-tumor necrosis factor-alpha-blocking agents.
    Koumakis E, Wipff J, Avouac J, Kahan A, Allanore Y.
    J Rheumatol; 2009 Sep; 36(9):2125-6. PubMed ID: 19738227
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Etanercept in rheumatoid arthritis.
    Cook DA, Dimick JB, Gallagher DC.
    N Engl J Med; 1999 Jun 24; 340(25):2000; author reply 2001. PubMed ID: 10383273
    [No Abstract] [Full Text] [Related]

  • 11. [Treatment of rheumatoid arthritis by inhibition of tumor necrosis factor with infliximab or etanercept].
    Tijhuis GJ, van de Putte LB, Breedveld FC.
    Ned Tijdschr Geneeskd; 2001 Sep 29; 145(39):1880-5. PubMed ID: 11605312
    [Abstract] [Full Text] [Related]

  • 12. Tumor necrosis factor-alpha blockade and the risk of vasculitis.
    Guillevin L, Mouthon L.
    J Rheumatol; 2004 Oct 29; 31(10):1885-7. PubMed ID: 15468348
    [No Abstract] [Full Text] [Related]

  • 13. TNFalpha therapy in psoriatic arthritis and psoriasis.
    Mease P.
    Ann Rheum Dis; 2004 Jul 29; 63(7):755-8. PubMed ID: 15194567
    [No Abstract] [Full Text] [Related]

  • 14. Tumor necrosis factor inactivation in the management of rheumatoid arthritis.
    Baumgartner SW.
    South Med J; 2000 Aug 29; 93(8):753-9. PubMed ID: 10963503
    [Abstract] [Full Text] [Related]

  • 15. Adalimumab in juvenile rheumatoid arthritis.
    Taddio A, Marchetti F.
    N Engl J Med; 2008 Dec 04; 359(23):2495-6; author reply 2496-7. PubMed ID: 19065749
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.